share_log

悦康药业最新公告:两款药品通过仿制药一致性评价

Stock Star ·  May 22 21:00

悦康药业公告,收到国家药品监督管理局核准签发的关于注射用头孢西丁钠(规格:1.0g)及注射用头孢米诺钠(规格:1.0g)的《药品补充申请批准通知书》,上述药品通过仿制药质量和疗效一致性评价。

以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment